Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s00280-017-3460-0
Published Online: 2017-11-07
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Murakami, Shuji
Saito, Haruhiro
Kondo, Tetsuro
Ito, Hiroyuki
Oshita, Fumihiro
Yamada, Kouzo
License valid from 2017-11-07